Applicant, as named in the Orange Book

Ibsa

Next listed expiry: Vybrique on 16 Dec 2033. 3 products with live protection, 1 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Vybrique · 4 strengths sildenafil citrate	sildenafil citrate	210858	16 Dec 2033	patent
Tirosint · 15 strengths levothyroxine sodium	levothyroxine sodium	021924	26 Sep 2044	patent
Tirosint-Sol · 15 strengths levothyroxine sodium	levothyroxine sodium	206977	26 Sep 2044	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (1)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Flector diclofenac epolamine	diclofenac epolamine	021234	open now	no listed protection